MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 48 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $177,182 | -47.4% | 14,405 | -86.5% | 0.00% | -50.0% |
| Q4 2019 | $337,000 | -29.9% | 107,098 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $481,000 | -49.0% | 107,098 | -31.3% | 0.00% | -50.0% |
| Q2 2019 | $943,000 | -16.1% | 155,846 | -3.7% | 0.01% | -14.3% |
| Q1 2019 | $1,124,000 | +72.1% | 161,774 | -4.3% | 0.01% | +75.0% |
| Q4 2018 | $653,000 | -28.6% | 169,074 | -1.5% | 0.00% | -20.0% |
| Q3 2018 | $914,000 | +6.5% | 171,574 | -1.8% | 0.01% | 0.0% |
| Q2 2018 | $858,000 | -25.6% | 174,774 | +22.0% | 0.01% | -28.6% |
| Q1 2018 | $1,153,000 | +26.8% | 143,265 | +61.6% | 0.01% | +40.0% |
| Q4 2017 | $909,000 | +74.8% | 88,640 | +147.7% | 0.01% | +66.7% |
| Q3 2017 | $520,000 | – | 35,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 633,297 | $3,109,000 | 0.58% |
| BVF INC/IL | 1,110,588 | $5,453,000 | 0.53% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 253,752 | $1,246,000 | 0.53% |
| Rubric Capital Management LP | 476,164 | $2,338,000 | 0.23% |
| Clearline Capital LP | 59,331 | $291,000 | 0.19% |
| Yakira Capital Management, Inc. | 66,934 | $329,000 | 0.08% |
| KEMPNER CAPITAL MANAGEMENT INC. | 14,898 | $73,000 | 0.05% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 20,725 | $106,000 | 0.04% |
| J. Goldman & Co LP | 100,000 | $491,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 22,731 | $112,000 | 0.02% |